Quent Capital’s MacroGenics MGNX Stock Holding History

Quent Capital’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-37,042	Closed	-$128K	–	1350
2022 Q3	$128K	Buy	37,042 +37,000	+88,095%	+$142K	0.03%	322
2022 Q2	$0	Hold	42	–	–	﹤0.01%	1259
2022 Q1	$0	Buy	+42	New	+$464	﹤0.01%	1300

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Quent Capital's MGNX Position: Q4 2022 in Review

Quent Capital sold out of MacroGenics (MGNX) in Q4 2022, closing a stake of 37,042 shares — an estimated $128K sold.

Quent Capital first reported a position in MGNX in Q1 2022 and held it in 3 quarters. The position peaked at $128K in Q3 2022. 135 funds tracked by Wall St. Rank hold MGNX as of Q4 2022.

Quent Capital reported no remaining MacroGenics position as of Q4 2022 after selling out during the quarter.
Quent Capital sold 37,042 MacroGenics shares in Q4 2022, an estimated $128K.
Quent Capital first reported a position in MacroGenics in Q1 2022 and held it in 3 quarters.
Quent Capital's MacroGenics position peaked at $128K in Q3 2022.
135 funds tracked by Wall St. Rank held MacroGenics as of Q4 2022.

Based on Quent Capital's 13F filing for Q4 2022, filed 19 Jan 2023.